Our Mission

The GLP-1 Collective supports individuals using GLP-1 medications by removing barriers to access, offering financial assistance, educating and empowering patients, and building a community where no one feels alone in their journey.

Our financial assistance program is launching soon. We’re actively fundraising to make it possible.

Who We Are

  • Christie Clutter

    Director

  • Amanda Bonello

    Founder | CEO | Host of the GLP-1 Collective Podcast | GLP-1 Patient | Advocate for Affordable Access

  • Sablle Titus

    Director

How We Began

It Started with a Petition

GLP-1 Collective is a patient advocacy group built by patients and led by patients, with a singular mission: ensuring affordable access for all who need it. Founded from a profound understanding of the obstacles faced by the GLP-1 community, we are committed to breaking down financial barriers and advocating for equitable healthcare. Our passion stems from real-life experiences, driving us to create a future where life-changing treatments are accessible to all.

Our FAQs

  • We support individuals who are using, seeking, or navigating access to prescribed GLP-1 medications as part of a healthcare provider’s treatment plan. This includes those managing chronic conditions like type 2 diabetes, obesity, PCOS, insulin resistance, and more — always under medical supervision.

  • GLP-1 medications can be life-changing for many people managing chronic, often stigmatized conditions. However, cost, insurance barriers, and stigma often prevent people from accessing the treatments recommended by their providers. Our goal is to reduce these barriers — through education, support, and advocacy — so patients can follow through with the care plans made by their medical teams.

  • We are open to partnerships with pharmaceutical companies and other healthcare organizations that align with our mission.

    We believe collaboration is key to creating meaningful, sustainable access. If a partnership helps patients and supports the programs we’ve built to serve them, we welcome the opportunity.

  • We provide non-clinical, community-based support for those prescribed GLP-1 medications, including:

    • Peer support groups

    • Educational webinars and Q&As with licensed experts

    • Advocacy toolkits and awareness campaigns

    • Financial aid navigation for those facing coverage gaps

    • Community outreach and events

    • Provider and service locators to help patients find GLP-1-informed care

    All programs are designed to complement, not replace, medical care.

  • There are many ways to get involved:

    • Donate or become a monthly supporter

    • Join our community on Discord for peer connection and updates

    • Share your story — anonymously or publicly — to help reduce stigma

    • Volunteer your time, skills, or lived experience

    • Partner with us as a sponsor, provider, or community advocate

    Every form of support helps us expand our impact and reach more people navigating prescribed GLP-1 treatment.

    Join the Collective.
    We’re building a growing coalition of patient advocates, care partners, and supporters committed to affordable, stigma-free access — and we’d love to have you with us.

  • No. We are a nonprofit advocacy and education organization.
    We do not provide medical care or prescriptions. Our work centers on connecting people with educational resources and helping them understand their options when working with licensed healthcare providers.

  • We were founded in Iowa by a patient advocate who recognized the need for GLP-1 support in local communities. While Iowa remains our home base and focus, our reach is expanding nationally — supporting patients across the U.S. through online resources, partnerships, and advocacy efforts.

  • Yes. We actively partner with:

    • Healthcare professionals

    • Nutrition and wellness brands

    • Universities and educators

    • Community programs

    • Advocacy organizations

    We believe every partner has something valuable to contribute when it comes to improving access and supporting people on their health journey.

  • We are pro-access.
    We support any pathway that helps people get safe, affordable treatment. That might include:

    • Manufacturer-driven solutions

    • Insurance coverage expansion

    • Compounded medications when appropriate

    • Fast-tracked generics

    • FDA pathways that increase competition and supply

    We believe in a whole-system approach, where prevention, treatment, and affordability work together.

  • All partnerships are built on mutual respect and transparency.
    We retain full control over our messaging, programming, and advocacy efforts. Our mission — helping patients access GLP-1s affordably and without stigma — guides every decision we make, including funding.

  • It means we’re open to all safe, legal, and effective ways to improve access to GLP-1 medications. We’re not tied to any one method — we’re focused on what works for patients. That flexibility allows us to work with a wide range of partners who share a common goal: better care for more people.